Non-toxic variants of the Escherichia coli heat-labile enterotoxin as mucosal immunogens and adjuvants

S.T.P. Pharma Sciences

Volumn 8, Issue 1, 1998, Pages 75-80

  De Haan, L ^a   Verweij, W R ^a   Feil, I K ^b   Holtrop, M ^a   Hol, W G J ^b   Agsteribbe, E ^a   Wilschut, J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Diphtheria toxoid; Immunization; Mucosal immunity; Pneumolysin; S IgA; Vaccine

Indexed keywords

ANTIGEN; DIPHTHERIA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; PNEUMOLYSIN; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; MOUSE; MUCOSA; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 0031917960     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. McGHEE J.R., MESTECKY J., DERTZBAUGH M.T., ELDRIDGE J.H., HIRASAWA M. and KIYONO H. - The mucosal immune system: from fundamental concepts to vaccine development. - Vaccine, 10, 75-88, 1992.
2. ALMEIDA A.J. and ALPAR H.O. - Nasal delivery of vaccines. -J. Drug Target., 3, 455-467, 1996.
3. DE HAAN A., GEERLIGS H.J., HUCHSHORN J.P., VAN SCHARRENBURG G.J.M., PALACHE A.M. and WILSCHUT J. - Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. - Vaccine, 13, 155-162, 1995.
4. HONE D.M., WU S., POWELL R.J., PASCUAL D.W., VAN COTT J., McGHEE J.R., FOUTS T.R., TUSKAN R.G. and LEWIS G.K. - Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. - J. Biotechnol., 44, 203-207, 1996.
5. NORIEGA F.R., LOSONSKY G., WANG J.Y., FORMAL S.B. and LEVINE M.M. - Further characterization of ΔaroA ΔvirG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector for delivering antigens of enterotoxigenic Escherichia coli. - Infect. Immun., 64, 23-27, 1996.
6. CLEMENTS J.D., HARTZOG N.M. and LYON F.L - Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. - Vaccine, 6, 269-277, 1988.
7. LYCKE N. and HOLMGREN J. - Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. - Immunology, 59, 301-308, 1986.
8. SPANGLER B.D. - Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. - Microbiol. Rev., 56, 622-647, 1992.
9. DE HAAN L, VERWEIJ W.R., FEIL I.K., LIJNEMA T.H., HOL W.G.J., AGSTERIBBE E. and WILSCHUT J. - Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. - Infect. Immun., 64, 5413-5416, 1996.
10. DICKINSON B.L. and CLEMENTS J.D. - Dissociation of Escherichia coliheat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. - Infect. Immun., 63, 1617-1623, 1995.
11. DI TOMMASO A., SALETTI G., PIZZA M., RAPPUOLI R., DOUGAN G., ABRIGNANI S., DOUCE G. and DE MAGISTRIS MT. - Induction of antigen-specific antibodies in vaginal secretions by using a non-toxic mutant of heat-labile enterotoxin as a mucosal adjuvant. - Infect. Immun., 64, 974-979, 1996.
12. DOUCE G., TURCOTTE C., CROPLEY I., ROBERTS M., PIZZA M., DOMENIGHINI M., RAPPUOLI R. and DOUGAN G. - Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as non-toxic, mucosal adjuvants.-Proc. Natl. Acad. Sci. USA, 92, 1644-1648, 1995.
13. FONTANA M.R., MANETTI R., GIANNELLI V., MAGAGNOLI C., MARCHINI A., OLIVIERI R., DOMENIGHINI M., RAPPUOLI R. and PIZZA M. - Construction of non-toxic derivatives of cholera toxin andcharacterization of the immunological response against the A subunit. - Infect. Immun., 63, 2356-2360, 1995.
14. PIZZA M., FONTANA M.R., GIULIANI M.M., DOMENIGHINI M., MAGAGNOLI C., GIANNELLI V., NUCCI D., HOL W.G.J., MANETTI R. and RAPPUOLI R. - A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. - J. Exp. Med., 180, 2147-2153, 1994.
15. LYCKE N., TSUJI T. and HOLMGREN J. - The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. - Eur. J. Immunol., 22, 2277-2281, 1992.
16. HAZAMA M., MAYUMI-AONO A., MIYAZAKI, T., HINUMA S. and FUJISAWA Y. - Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. -Immunology, 78, 643-649, 1993.
17. GIANNELLI V., FONTANA M.R., GIULIANI M.M., GUANGCAI D., RAPPUOLI R. and PIZZA M. - Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loop. - Infect. Immun., 65, 331-334, 1997.
18. UESAKA Y., OTSUKA Y., LIN Z., YAMASAKI S., YAMAOKA J., KURAZONO H. and TAKEDA Y. - Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. - Microb. Pathog., 16, 71-76, 1994.
19. FEIL I.K., REDDY R., DE HAAN L, MERRITT E.A., VAN DEN AKKER F., STORM D.R. and HOL W.G.J. - Protein engineering studies of A-chain loop 47-56 of E. coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. - Mol. Microbiol., 20, 823-832, 1996.
20. DE HAAN L., VERWEIJ W.R., HOLTROP M., AGSTERIBBE E. and WILSCHUT J. - Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit. - Vaccine, 14, 620-626, 1996.
21. ALEXANDER J.E., LOCK R.A., PEETERS C.C.A.M., POOLMAN J.T., ANDREW P.W., MITCHELL T.J., HANSMAN D. and PATON J.C. - Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcuspneumoniae. - Infect. Immun., 62, 5683-5688, 1994.
22. TAMURA S.I., SAMEGAI Y., KURATA H., NAGAMINE T., AIZAWA C. and KURATA T. - Protection against influenza virus infection by a vaccine inocculated with cholera toxin B subunit. -Vaccine, 6, 409-415, 1988.
23. WU W.Y. and RUSSELL M.W. - Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. - Infect. Immun., 61, 314-322, 1993.
24. CZERKINSKY C., RUSSELL M.W., LYCKE N., LINDBLAD M., and HOLMGREN J. - Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. - Infect. Immun., 57, 1072-1077, 1989.
25. TAMURA S.-I, YAMANAKA A., SHIMOHARA M., TOMITA T., KOMASE K., TSUDA T., SUZUKI Y., NAGAMINE T., KAWAHARA K., DANBARA H., AIZAWA C., OYA A. and KURATA T. - Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.-Vaccine, 12,419-426, 1994.
26. HOLMGREN J., LYCKE N. and CZERKINSKY C. - Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. - Vaccine, 11, 1179-1184, 1993.
27. SANCHEZ J.L., VASQUEZ B., BEGUE R.E. et al. - Protective efficacy of oral whole cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. - Lancet, 344, 1273-1276, 1994.
28. VERWEIJ W.R., DE HAAN L., HOLTROP M., AGSTERIBBE E. and WILSCHUT J. - Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza surface antigen. - Submitted.
29. YAMAMOTO S., TAKEDA Y., YAMAMOTO M., KURAZONO H., IMAOKA K., YAMAMOTO M., FUJIHASHI K., NODA M., KIYONO H., and McGHEE J.R. - Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. - J. Exp. Med., 185, 1203-1210, 1997.
30. SNIDER D.P. - The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. - Crit. Rev. Immunol., 15, 317-348, 1996.